Sfoglia per Autore
High Sensitivity Mutation Monitoring and Clonal Analysis by Ultra-Deep Amplicon Sequencing Uncover the Complexity of BCR-ABL Mutation Status in Philadelphia+ Patients Treated with Tyrosine Kinase Inhibitors
2012 Soverini S.; De Benedittis C.; Castagnetti F.; Papayannidis C.;Gugliotta G.; Iacobucci I.; Venturi C.; Bochicchio MT.; Cattina F.; Russo D.; Rosti G.; Baccarani M.; Martinelli G.
EARLY PREDICTORS OF PROGRESSION TO ACCELERATED-BLASTIC PHASE IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH NILOTINIB-BASED REGIMENS
2012 G Gugliotta; F Castagnetti; F Palandri; M Breccia; L Levato; F Stagno; G Rege Cambrin; A Zaccaria; G Specchia; E Usala; A Gozzini; B Martino; A Capucci; I Pierri; M Tiribelli; M Bocchia; E Abruzzese; S Soverini; N Testoni; G Saglio; G Martinelli; F Pane; G Alimena; G Rosti; M Baccarani
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology
2012 Soverini S; De Benedittis C; Gnani A; Iacobucci I; Castagnetti F; Gugliotta G; Papayannidis C; Cattina F; Russo D; Pantaleo MA; Rosti G; Baccarani M; Martinelli G
High Sensitivity Mutation Screening and Clonal Analysis Allowed by Ultra-Deep Amplicon Sequencing Uncover the Complexity of Bcr-Abl Mutation Status in Patients Treated with Tyrosine Kinase Inhibitors
2012 S Soverini; C De Benedittis; F Cattina; A Broucková; K Machová Poláková; D Russo; A Gnani; I Iacobucci; MT Bochicchio; F Castagnetti; G Gugliotta; F Palandri; C Papayannidis; H Klamová; A Vitale; M Vignetti; R Foà; G Rosti; M Baccarani; G Martinelli
Frontline Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: a Phase 2 Multicentric Study
2012 F Castagnetti; G Rosti; M Breccia; F Stagno; A Gozzini; G Specchia; A Capucci; B Martino; G Rege Cambrin; L Luciano; E Abruzzese; M Bocchia; F Cavazzini; M Tiribelli; I Pierri; G Gugliotta; F Palandri; S Durante; S Soverini; N Testoni; F Pane; G Saglio; G Alimena; G Martinelli; M Baccarani
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase
2012 Gianantonio Rosti;Fausto Castagnetti;Gabriele Gugliotta;Francesca Palandri;Michele Baccarani
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis
2012 S Luatti; F Castagnetti; G Marzocchi; C Baldazzi; G Gugliotta; I Iacobucci; G Specchia; L Zanatta; G Rege-Cambrin; M Mancini; E Abruzzese; A Zaccaria; M G Grimoldi; A Gozzetti; G Ameli; M A Capucci; G Palka; P Bernasconi; F Palandri; F Pane; G Saglio; G Martinelli; G Rosti; M Baccarani; N Testoni; on behalf of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Working Party on CML
Physician’s guide to the clinical management of adverse events on nilotinib therapy for the treatment of CML
2012 Gianantonio Rosti;Fausto Castagnetti;Gabriele Gugliotta;Francesca Palandri;Michele Baccarani
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain
2013 Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli
High frequency of small insertions and deletions in the BCR-ABL Kinase Domain revealed by ultra-deep sequencing
2013 De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F,Gugliotta G, Palandri F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, Bochicchio MT, Cattina F, Mancini M, Leo E, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G
Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain
2013 Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli
Diagnosis and classification of the risk
2013 Gugliotta, Gabriele; Castagnetti, Fausto; Palandri, Francesca; Baccarani, Michele; Rosti, Gianantonio
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
2013 Latagliata R.; Breccia M.; Fava C.; Stagno F.; Tiribelli M.; Luciano L.; Gozzini A.; Gugliotta G.; Annunziata M.; Cavazzini F.; Ferrero D.; Musto P.; Capodanno I.; Iurlo A.; Visani G.; Crugnola M.; Calistri E.; Castagnetti F.; Vigneri P.; Alimena G.
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain.
2013 Soverini S; De Benedittis C; Machova Polakova K; Brouckova A; Horner D; Iacono M; Castagnetti F; Gugliotta G; Palandri F; Papayannidis C; Iacobucci I; Venturi C; Bochicchio MT; Klamova H; Cattina F; Russo D; Bresciani P; Binotto G; Giannini B; Kohlmann A; Haferlach T; Roller A; Rosti G; Cavo M; Baccarani M; Martinelli G.
Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors.
2013 Gugliotta G;Castagnetti F;Fogli M;Cavo M;Baccarani M;Rosti G
Deep sequencing of the BCR-ABL kinase domain reveals a frequency of 35INS insertion/truncation higher than expected
2013 De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F, Gugliotta G, Palandri F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, MT Bochicchio, Cattina F, Mancini M, Elisa L, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G.
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia.
2013 Russo D; Martinelli G; Malagola M; Skert C; Soverini S; Iacobucci I; De Vivo A; Testoni N; Castagnetti F; Gugliotta G; Turri D; Bergamaschi M; Pregno P; Pungolino E; Stagno F; Breccia M; Martino B; Intermesoli T; Fava C; Abruzzese E; Tiribelli M; Bigazzi C; Cesana BM; Rosti G; Baccarani M.
Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy
2013 Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Ilaria Iacobucci, Claudia Venturi, Manuela Mancini, Elisa Leo, Hana Klamova, Stefania Paolini, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells
2013 Manuela Mancini;Elisa Leo;Ken-Ichi Takemaru;Virginia Campi;Enrica Borsi;Fausto Castagnetti;Gabriele Gugliotta;Maria Alessandra Santucci;Giovanni Martinelli
Imatinib in Very Elderly Patients with Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Study
2013 Roberto Latagliata;Dario Ferrero;Alessandra Iurlo;Francesco Cavazzini;Fausto Castagnetti;Elisabetta Abruzzese;Carmen Fava;Massimo Breccia;Mario Annunziata;Fabio Stagno;Mario Tiribelli;Gianni Binotto;Giovanna Mansueto;Antonella Gozzini;Sabina Russo;Laura Cavalli;Enrico Montefusco;Gabriele Gugliotta;Michele Cedrone;Antonella Russo Rossi;Paolo Avanzini;Patrizia Pregno;Endri Mauro;Antonio Spadea;Francesca Celesti;Gianfranco Giglio;Alessandro Isidori;Monica Crugnola;Elisabetta Calistri;Federica Sorà;Stefano Storti;Ada D’Addosio;Giovanna Rege-Cambrin;Luigiana Luciano;Giuliana Alimena
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| High Sensitivity Mutation Monitoring and Clonal Analysis by Ultra-Deep Amplicon Sequencing Uncover the Complexity of BCR-ABL Mutation Status in Philadelphia+ Patients Treated with Tyrosine Kinase Inhibitors | Soverini S.; De Benedittis C.; Castagnetti F.; Papayannidis C.;Gugliotta G.; Iacobucci I.; Ventur...i C.; Bochicchio MT.; Cattina F.; Russo D.; Rosti G.; Baccarani M.; Martinelli G. | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| EARLY PREDICTORS OF PROGRESSION TO ACCELERATED-BLASTIC PHASE IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH NILOTINIB-BASED REGIMENS | G Gugliotta; F Castagnetti; F Palandri; M Breccia; L Levato; F Stagno; G Rege Cambrin; A Zaccaria...; G Specchia; E Usala; A Gozzini; B Martino; A Capucci; I Pierri; M Tiribelli; M Bocchia; E Abruzzese; S Soverini; N Testoni; G Saglio; G Martinelli; F Pane; G Alimena; G Rosti; M Baccarani | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology | Soverini S; De Benedittis C; Gnani A; Iacobucci I; Castagnetti F; Gugliotta G; Papayannidis C; Ca...ttina F; Russo D; Pantaleo MA; Rosti G; Baccarani M; Martinelli G | 2012-01-01 | CANCER RESEARCH | American Association of Cancer Research | 4.02 Riassunto (Abstract) | - |
| High Sensitivity Mutation Screening and Clonal Analysis Allowed by Ultra-Deep Amplicon Sequencing Uncover the Complexity of Bcr-Abl Mutation Status in Patients Treated with Tyrosine Kinase Inhibitors | S Soverini; C De Benedittis; F Cattina; A Broucková; K Machová Poláková; D Russo; A Gnani; I Iaco...bucci; MT Bochicchio; F Castagnetti; G Gugliotta; F Palandri; C Papayannidis; H Klamová; A Vitale; M Vignetti; R Foà; G Rosti; M Baccarani; G Martinelli | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Frontline Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: a Phase 2 Multicentric Study | F Castagnetti; G Rosti; M Breccia; F Stagno; A Gozzini; G Specchia; A Capucci; B Martino; G Rege ...Cambrin; L Luciano; E Abruzzese; M Bocchia; F Cavazzini; M Tiribelli; I Pierri; G Gugliotta; F Palandri; S Durante; S Soverini; N Testoni; F Pane; G Saglio; G Alimena; G Martinelli; M Baccarani | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase | Gianantonio Rosti;Fausto Castagnetti;Gabriele Gugliotta;Francesca Palandri;Michele Baccarani | 2012-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis | S Luatti; F Castagnetti; G Marzocchi; C Baldazzi; G Gugliotta; I Iacobucci; G Specchia; L Zanatta...; G Rege-Cambrin; M Mancini; E Abruzzese; A Zaccaria; M G Grimoldi; A Gozzetti; G Ameli; M A Capucci; G Palka; P Bernasconi; F Palandri; F Pane; G Saglio; G Martinelli; G Rosti; M Baccarani; N Testoni; on behalf of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Working Party on CML | 2012-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Physician’s guide to the clinical management of adverse events on nilotinib therapy for the treatment of CML | Gianantonio Rosti;Fausto Castagnetti;Gabriele Gugliotta;Francesca Palandri;Michele Baccarani | 2012-01-01 | CANCER TREATMENT REVIEWS | - | 1.01 Articolo in rivista | - |
| Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain | Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Casta...gnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli | 2013-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| High frequency of small insertions and deletions in the BCR-ABL Kinase Domain revealed by ultra-deep sequencing | De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F,Gugliotta G, Palandri... F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, Bochicchio MT, Cattina F, Mancini M, Leo E, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G | 2013-01-01 | HAEMATOLOGICA | - | 1.06 Abstract in rivista | - |
| Minor Subclones Harboring Small Insertions and Deletions Probably Due To Aberrant Splicing Can Frequently Be Detected By Deep Sequencing of The BCR-ABL Kinase Domain | Caterina De Benedittis, Simona Soverini, Katerina Machova Polakova, Adela Brouckova, Fausto Casta...gnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Hana Klamova, Paola Bresciani, Marzia Salvucci, Gianni Binotto, Tamara Intermesoli, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Maria Teresa Bochicchio, Manuela Mancini, Elisa Leo, Torsten Haferlach, Alexander Kohlmann, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli | 2013-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| Diagnosis and classification of the risk | Gugliotta, Gabriele; Castagnetti, Fausto; Palandri, Francesca; Baccarani, Michele; Rosti, Gianant...onio | 2013-01-01 | - | Future Medicine Ltd. | 2.01 Capitolo / saggio in libro | - |
| Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia. | Latagliata R.; Breccia M.; Fava C.; Stagno F.; Tiribelli M.; Luciano L.; Gozzini A.; Gugliotta G....; Annunziata M.; Cavazzini F.; Ferrero D.; Musto P.; Capodanno I.; Iurlo A.; Visani G.; Crugnola M.; Calistri E.; Castagnetti F.; Vigneri P.; Alimena G. | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain. | Soverini S; De Benedittis C; Machova Polakova K; Brouckova A; Horner D; Iacono M; Castagnetti F; ...Gugliotta G; Palandri F; Papayannidis C; Iacobucci I; Venturi C; Bochicchio MT; Klamova H; Cattina F; Russo D; Bresciani P; Binotto G; Giannini B; Kohlmann A; Haferlach T; Roller A; Rosti G; Cavo M; Baccarani M; Martinelli G. | 2013-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors. | Gugliotta G;Castagnetti F;Fogli M;Cavo M;Baccarani M;Rosti G | 2013-01-01 | EXPERT REVIEW OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Deep sequencing of the BCR-ABL kinase domain reveals a frequency of 35INS insertion/truncation higher than expected | De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F, Gugliotta G, Palandr...i F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, MT Bochicchio, Cattina F, Mancini M, Elisa L, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G. | 2013-01-01 | HAEMATOLOGICA | - | 1.06 Abstract in rivista | - |
| Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia. | Russo D; Martinelli G; Malagola M; Skert C; Soverini S; Iacobucci I; De Vivo A; Testoni N; Castag...netti F; Gugliotta G; Turri D; Bergamaschi M; Pregno P; Pungolino E; Stagno F; Breccia M; Martino B; Intermesoli T; Fava C; Abruzzese E; Tiribelli M; Bigazzi C; Cesana BM; Rosti G; Baccarani M. | 2013-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy | Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Fausto Casta...gnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Ilaria Iacobucci, Claudia Venturi, Manuela Mancini, Elisa Leo, Hana Klamova, Stefania Paolini, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli | 2013-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells | Manuela Mancini;Elisa Leo;Ken-Ichi Takemaru;Virginia Campi;Enrica Borsi;Fausto Castagnetti;Gabrie...le Gugliotta;Maria Alessandra Santucci;Giovanni Martinelli | 2013-01-01 | CELLULAR SIGNALLING | - | 1.01 Articolo in rivista | - |
| Imatinib in Very Elderly Patients with Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Study | Roberto Latagliata;Dario Ferrero;Alessandra Iurlo;Francesco Cavazzini;Fausto Castagnetti;Elisabet...ta Abruzzese;Carmen Fava;Massimo Breccia;Mario Annunziata;Fabio Stagno;Mario Tiribelli;Gianni Binotto;Giovanna Mansueto;Antonella Gozzini;Sabina Russo;Laura Cavalli;Enrico Montefusco;Gabriele Gugliotta;Michele Cedrone;Antonella Russo Rossi;Paolo Avanzini;Patrizia Pregno;Endri Mauro;Antonio Spadea;Francesca Celesti;Gianfranco Giglio;Alessandro Isidori;Monica Crugnola;Elisabetta Calistri;Federica Sorà;Stefano Storti;Ada D’Addosio;Giovanna Rege-Cambrin;Luigiana Luciano;Giuliana Alimena | 2013-01-01 | DRUGS & AGING | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile